GP
JNJ icon

Geneva Partners’s Johnson & Johnson JNJ Stock Holding History

Geneva Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,674
Closed -$570K – 81
2023
Q1 		$570K Sell
3,674
-170
-4% -$27.4K 0.49% 42
2022
Q4 		$679K Sell
3,844
-25
-0.6% -$4.32K 0.64% 36
2022
Q3 		$632K Sell
3,869
-300
-7% -$50.8K 0.72% 31
2022
Q2 		$740K Buy
4,169
+155
+4% +$27.6K 0.73% 32
2022
Q1 		$711K Sell
4,014
-5,215
-57% -$887K 0.44% 48
2021
Q4 		$1.58M Buy
9,229
+2,730
+42% +$447K 0.75% 37
2021
Q3 		$1.05M Buy
6,499
+1,421
+28% +$242K 0.5% 46
2021
Q2 		$837K Buy
+5,078
New +$841K 0.38% 56
2020
Q3 		– Sell
-3,300
Closed -$464K – 89
2020
Q2 		$464K Buy
+3,300
New +$481K 0.33% 59

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Geneva Partners's JNJ Position: Q2 2023 in Review

Geneva Partners sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 3,674 shares — an estimated $570K sold.

Geneva Partners first reported a position in JNJ in Q2 2020 and held it in 9 quarters. The position peaked at $1.58M in Q4 2021. 3,752 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • Geneva Partners reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • Geneva Partners sold 3,674 Johnson & Johnson shares in Q2 2023, an estimated $570K.
  • Geneva Partners first reported a position in Johnson & Johnson in Q2 2020 and held it in 9 quarters.
  • Geneva Partners's Johnson & Johnson position peaked at $1.58M in Q4 2021.
  • 3,752 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Geneva Partners's 13F filing for Q2 2023, filed 3 Aug 2023.